Last updated on November 2017

Ulcerative Colitis and Crohn’s Disease (IBD) Research Study


Brief description of study

Ulcerative Colitis and Crohn’s Disease (IBD) Research Study

Detailed Study Description

Chevy Chase Clinical Research would like to invite you to participate in a clinical research study evaluating the effectiveness of a medication for Ulcerative Colitis and Crohn’s Disease (IBD).

Qualified participants must be:

  • Ages 18 and over
  • Have been previously diagnosed with Ulcerative Colitis and Crohn’s Disease (IBD)

All study-related care is provided at no charge including physical examinations, lab tests, and study medication. Financial compensation is also provided.

For further information, please contact

Clinical Study Identifier: TX16220

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Robert Hardi, M.D., CPI

MGG Group Co., Inc., Chevy Chase Clinical Research
Chevy Chase, MD USA
  Connect »